Oramed Pharmaceuticals Inc. (ORMP) 13D/13G Filings for Scilex Holding Company (SCLX)

Oramed Pharmaceuticals Inc. 13D and 13G filings for Scilex Holding Company:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-17
4:15 pm
Purchase
2025-01-1313GScilex Holding Company
SCLX
ORAMED PHARMACEUTICALS INC.
ORMP
15,500,000
6.200%
15,500,000increase
(New Position)
Filing